Evidence map›Paper›PMID 29768197›Full record

ArticleCell reports2018

Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer.

Noa Stettner, Chava Rosen, Biana Bernshtein, Shiri Gur-Cohen, Julia Frug, Alon Silberman, Alona Sarver, Narin N Carmel-Neiderman, Raya Eilam, Inbal Biton and 13 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry toInternational journal of molecular sciences · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 3 countries.

Noa StettnerDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel; Koret School of Veterinary Medicine, Hebrew University, Rehovot, Israel.
Chava RosenDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel; The Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel.
Biana BernshteinDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Shiri Gur-CohenDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Julia FrugDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Alon SilbermanDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Alona SarverDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Narin N Carmel-NeidermanDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Raya EilamDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Inbal BitonDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Meirav Pevsner-FischerDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Niv ZmoraDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Alexander BrandisDepartment of Biological Services, Weizmann Institute of Science, Rehovot, Israel.
Keren Bahar HalpernDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Ram MazkerethThe Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Diego di BernardoTelethon Institute of Genetics and Medicine, Pozzuoli, Italy; Department of Chemical, Materials and Industrial Engineering, Federico II University, Naples, Italy.
Nicola Brunetti-PierriTelethon Institute of Genetics and Medicine, Pozzuoli, Italy; Department of Translational Medicine, Federico II University, Naples, Italy.
Muralidhar H PremkumarDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Texas Children's Hospital, Houston, TX, USA.
Gillian DankKoret School of Veterinary Medicine, Hebrew University, Rehovot, Israel.
Sandesh C S NagamaniTexas Children's Hospital, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Steffen JungDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Alon HarmelinDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Ayelet ErezDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. Electronic address: ayelet.erez@weizmann.ac.il.
Weizmann Institute of Science · ILTexas Children's Hospital · USFederico II University Hospital · ITHebrew University of Jerusalem · ILTel Aviv University · ILTelethon Institute Of Genetics And Medicine · IT

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, SAMACO, RODNEY C · 2014 to 2019
$7.8M
NICHD NIH HHS U54 HD083092
6 · The paper itself

Abstract

Nitric oxide (NO) plays an established role in numerous physiological and pathological processes, but the specific cellular sources of NO in disease pathogenesis remain unclear, preventing the implementation of NO-related therapy. Argininosuccinate lyase (ASL) is the only enzyme able to produce arginine, the substrate for NO generation by nitric oxide synthase (NOS) isoforms. Here, we generated cell-specific conditional ASL knockout mice in combination with genetic and chemical colitis models. We demonstrate that NO derived from enterocytes alleviates colitis by decreasing macrophage infiltration and tissue damage, whereas immune cell-derived NO is associated with macrophage activation, resulting in increased severity of inflammation. We find that induction of endogenous NO production by enterocytes with supplements that upregulate ASL expression and complement its substrates results in improved epithelial integrity and alleviation of colitis and of inflammation-associated colon cancer.

Indexed as

AnimalsArginineArgininosuccinate LyaseColitisColonic NeoplasmsEnterocytesEpithelial CellsInflammationMice, Inbred C57BLMice, KnockoutNitric OxideArginineArgininosuccinate LyaseNitric OxideIBDinflammation-associated colon cancerneutraceutical supplementsnitric oxide metabolism

Identifiers

PMID29768197
PMCPMC5976577
OpenAlexW2803758722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.